Scientific Reports (Mar 2022)

Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India

  • Amit Rawat,
  • Rahul Tyagi,
  • Himanshi Chaudhary,
  • Vignesh Pandiarajan,
  • Ankur Kumar Jindal,
  • Deepti Suri,
  • Anju Gupta,
  • Madhubala Sharma,
  • Kanika Arora,
  • Amanjit Bal,
  • Priyanka Madaan,
  • Lokesh Saini,
  • Jitendra Kumar Sahu,
  • Yumi Ogura,
  • Tamaki Kato,
  • Kohsuke Imai,
  • Shigeaki Nonoyama,
  • Surjit Singh

DOI
https://doi.org/10.1038/s41598-022-08019-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Germline ATM gene variations result in phenotypic heterogeneity characterized by a variable degree of disease severity. We retrospectively collected clinical, genetic, and immunological data of 26 cases with A-T. Clinical manifestations included oculocutaneous telangiectasia (100%), ataxia (100%), fever, loose stools or infection (67%), cerebellar atrophy (50%), nystagmus (8%), dysarthria (15.38%), and visual impairment (8%). Genetic analysis confirmed ATM gene variations in 16 unrelated cases. The most common type of variation was stopgain variants (56%). Immunoglobulin profile indicated reduced IgA, IgG, and IgM in 94%, 50%, and 20% cases, respectively. T cell lymphopenia was observed in 80% of cases among those investigated. Unusual presentations included an EBV-associated smooth muscle tumour located in the liver in one case and Hyper IgM syndrome-like presentation in two cases. Increased immunosenescence was observed in T-cell subsets (CD4+CD57+ and CD8+CD57+). T-cell receptor excision circles (TRECs) were reduced in 3/8 (37.50%) cases.